Apoptosis is triggered by activation of initiator caspases upon complexmediated clustering of the inactive zymogen, as occurs in the caspase-9 -activating apoptosome complex. Likewise, caspase-2, which is involved in stress-induced apoptosis, is recruited into a large protein complex, the molecular composition of which remains elusive. We show that activation of caspase-2 occurs in a complex that contains the death domain-containing protein PIDD, whose expression is induced by p53, and the adaptor protein RAIDD. Increased PIDD expression resulted in spontaneous activation of caspase-2 and sensitization to apoptosis by genotoxic stimuli. Because PIDD functions in p53-mediated apoptosis, the complex assembled by PIDD and caspase-2 is likely to regulate apoptosis induced by genotoxins.
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Caspase-2 is the most evolutionarily conserved caspase (1), but its role in apoptosis remains enigmatic and controversial, despite the fact that it was the second mammalian caspase to be identified (2, 3) . Although a role for caspase-2 in apoptosis initiated by ␤-amyloid cytotoxicity (4), trophic factor deprivation (5) , and granzyme B (6) has been proposed, the interest in this caspase has been dampened due to the lack of an overt phenotype of caspase-2-deficient mice and limited knowledge of its mode of activation and downstream targets. Nevertheless, caspase-2 is required in stressinduced apoptosis (7), and caspase-2-deficient germ cells and oocytes are resistant to cell death after treatment with chemotherapeutic drugs (6). It acts upstream of mitochondria, by inducing Bid cleavage, Bax translocation to mitochondria, and subsequent cytochrome c release (7) (8) (9) . Caspase-2-induced apoptosis requires caspase-9 (9), and when added to purified mitochondria, only caspase-2 can directly cause cytochrome c release (8, 9) .
Caspase-2 has a caspase-recruitment domain (CARD) pro-domain which, when overexpressed, associates with RAIDD, an adaptor protein containing a CARD and a death domain (DD) (10) . RAIDD was proposed to interact with RIP1 and thereby to link tumor necrosis factor R1 (TNF-R1) activation with caspase-2-mediated apoptosis (10, 11) . This notion could not be confirmed, however (6, 12) .
We therefore sought to identify the molecular complex responsible for caspase-2 activation. Because caspases with CARD pro-domains usually are activated by CARD-containing proteins, we expressed CARD-containing proteins and tested their possible interaction with the CARD of caspase-2. The only interaction partner identified was RAIDD (13) , in agreement with previous results (10, 11) , which interacted specifically with caspase-2 and not with any of the other CARD-containing initiator caspases (Fig.  1A) . Using a similar approach, we identified an interaction partner that bound the DD of RAIDD. Of the more than 20 different proteins analyzed, PIDD (p53-induced protein with a DD) was the only protein that was found to interact with RAIDD (Fig. 1B) . Through overexpression, a PIDD-RAIDD-caspase-2 trimolecular complex could be reconstituted (Fig. 1C) . A cooperativity between all three components to generate a stable complex was observed.
PIDD was initially identified as a prime p53 target gene in an erythroleukemia cell line that undergoes G 1 phase arrest and subsequent apoptosis after p53 expression (14) . Independently, PIDD was also described as a DD-containing protein with unknown function (15) . The N-terminal region of PIDD contains seven leucine-rich repeats (LRRs), a protein interaction motif found in various proteins with diverse functions (Fig. 1D) , followed by two ZU-5 domains and a Cterminal DD. Prototypical ZU-5 interaction domains are present in the tight junction protein ZO-1, ankyrin, and Unc5-like netrin receptors. Expression of PIDD is widespread, but it is highest in the spleen (14) . Expression of PIDD is elevated in cells transiently expressing p53 (14) . The full-length protein contains 910 amino acids, migrates at ϳ90 kD, and is frequently cleaved into two fragments of 48 kD (N-terminal region) and 51 kD (C-terminal region) [ Fig. 1E and (15)]. The size of the fragment indicates that an unknown protease may cleave between the two ZU-5 domains [cleavage not inhibitable by z-Val-Ala-Asp-fmk (zVAD-fmk) (13) ]. Processing does not result in the dissociation of the two fragments (13) .
We next investigated whether the PIDD-RAIDD-caspase-2 complex (the PIDDosome) also forms under more physiological conditions. The characterization of a caspase-2-containing complex that is distinct from the Apaf-1-caspase-9 apoptosome was described (16) . Formation of the caspase-2-containing complex occurred spontaneously in cell lysates after incubation at 37°C for 1 hour (16), which is in marked contrast to apoptosome formation that requires the addition of 2Ј-deoxyadenosine 5Ј-triphosphate (dATP) and cytochrome c. In agreement with the published data, spontaneous caspase-2 complex formation was detectable in cell extracts from HeLa cells (human cervical carcinoma), Jurkat T cells (human leukemia T cell), 293T cells (human embryonic kidney cells), or Ramos B lymphocytes (human Burkitt's lymphoma) [ Fig. 2 , A and B, and (13)]. When cell extracts incubated at 4°C were analyzed by gel-filtration chromatography, caspase-2 eluted mainly in fractions corresponding to Department of Biochemistry, University of Lausanne, Chemin des Boveresses 155, CH-1066 Epalinges, Switzerland.
*To whom correspondence should be addressed. Email: jurg.tschopp@ib.unil.ch the monomeric protease (50 kD), whereas incubation of extracts at 37°C caused more caspase-2 to elute in fractions corresponding to a molecular mass of Ͼ670 kD. The same shift was observed for RAIDD. Complex formation was also observed when only the PIDD-interacting DD of RAIDD, but not the CARD of RAIDD, was expressed, which suggests that assembly of RAIDD into a complex is PIDD-dependent ( fig. S1 ). Unlike caspase-2 and RAIDD, PIDD was already present in a complex of ϳ550 kD prior to incubation at 37°C (Fig. 2B) . The size of the PIDD complex further increased in response to a temperature elevation. Taken together, these data suggested that PIDD, RAIDD, and caspase-2 spontaneously assemble into a high-molecular-weight complex, when all three components are present in the same cell extract.
Caspase-2 is an initiator caspase for which proteolytic processing is not absolutely required for activation (17, 18) . To detect unequivocally active caspase-2, we incubated cell extracts of 293T cells overexpressing various PIDDosome components with biotinylated VAD-fmk, an inhibitor that irreversibly binds to the exposed active site of caspases (Fig. 3A) . Subsequent streptavidin precipitates revealed that overexpression of either RAIDD or PIDD resulted in the generation of enzymatically active caspase-2. Activation by PIDD was dependent on the presence of endogenous RAIDD, because ablation of RAIDD expression by small, interfering RNA (siRNA) blocked caspase-2 processing (Fig. 3A) . Overexpression of other apoptosis inducers, such as RIP1 or caspase-9, resulted in strong activation of caspase-3 but not of caspase-2 (Fig. 3A) . Thus, PIDD-induced caspase-2 activation appears not to rely on caspase-3, a conclusion supported by the observation that PIDD-mediated caspase-2 processing was not impaired in caspase-3-deficient MCF7 cells ( fig. S2 ).
We next examined whether caspase-2 activation occurs not only when the concentration of PIDD is artificially increased, but also in the spontaneously assembling PIDDosome in cell extracts of Jurkat T cells. Even though VADfmk is not a specific inhibitor of caspase-2, the remaining initiator caspases are not spontaneously activated in Jurkat T cells under the conditions of cell rupture that we used [(16) and see below]. Thus it was feasible to use biotin-VAD-fmk to immunoprecipitate only the active form of caspase-2. The amount of caspase-2 bound to biotin-VAD increased over time and reached a plateau after 60 min (Fig. 3B) . In agreement with the fact that cleavage of initiator caspases is not required for activity, the majority of caspase-2 was found in its precursor form. Along with caspase-2, RAIDD and PIDD were coprecipitated, which indicated that caspase-2 is activated during complex formation. Recruitment of RAIDD was not detectable in murine embryonic fibroblasts deficient in caspase-2 ( fig. S3 ), which confirmed that caspase-2 is the only caspase that spontaneously interacts with RAIDD when cells rupture. Spontaneous assembly of PIDD, RAIDD, and caspase-2 was also observed when PIDD, instead of caspase-2, was immunoprecipitated (Fig. 3C) . Recruitment of RAIDD and caspase-2 was observed in a time-dependent manner. Unlike recruitment of caspase-2 with biotin--VAD-fmk, which partially blocks processing of caspase-2 in cell extracts, the processed form of caspase-2 was detected in the PIDD complex. Caspase-2 activation was dependent on PIDD and RAIDD. Decreasing RAIDD or PIDD expression with siRNA abrogated the time-dependent caspase-2 activation, which indicated that the PIDDosome plays an important role in caspase-2 activation (Fig. 3D) .
What is the physiological role of PIDDosome-induced caspase-2 activation? Transient overexpression of large amounts of PIDD resulted in slow cell death (14) , associated with caspase-2 activation (Fig. 3A) . Despite this, we were able to generate HeLa and B cell Ramos cells that stably expressed PIDD (Fig. 4A) . In these PIDD-expressing cells, almost 50% of caspase-2 was processed, which indicated that an increase of PIDD concentration led to caspase activation (Fig. 4A) . Spontaneous activation of caspase-2 in PIDD-expressing cells was confirmed when binding of biotin-VAD was analyzed. In contrast, cells expressing PIDD lacking the DD behaved like wild-type cells, and no caspase-2 activation was detectable, despite similar expression levels (13) , which indicated that the RAIDD-interacting DD of PIDD was essential for caspase-2 activation.
Given that an increase of PIDD concentration triggers the activation of caspase-2 in living cells, we expect that PIDDosome complexes will be present in such cells expressing exogenous PIDD. Indeed, a fraction of caspase-2 and RAIDD were found in highmolecular-weight complexes without the need of prior incubation of cell extracts at 37°C (Fig. 4B) .
A striking difference between PIDD-expressing cells and wild-type cells became apparent when cells were exposed to genotoxic stress. Within 5 hours after exposure to the topoisomerase inhibitors doxorubicin (Fig. 4C) or etoposide (13), 60% of the cells were dead, whereas in wild-type cells or cells expressing PIDD⌬DD, most of the cells remained viable. This difference was also reflected at the level of caspase activation. In PIDD-expressing cells, the remaining, unprocessed caspase-2 was almost completely processed into the p19 fragment, and the activity of caspase-3 was highly increased as evidenced by the cleavage of poly(ADP-ribose) polymerase-1 (PARP1) (19) .
Inhibition of PIDD expression attenuates p53-induced apoptosis, whereas overexpression of PIDD inhibits cell growth (14) . Thus, PIDD appears to be a crucial target gene of a signaling pathway that is triggered when activated by p53 and ultimately leads to apoptosis. An increase of PIDD concentration promotes activation of caspase-2, as do stress conditions at low PIDD concentrations, as in our experiments on cell extracts. PIDD may tend to oligomerize, but the ultimate trigger leading to assembly seems to be a stress-related signal of unknown nature. Although the apoptosome-induced activation of caspase-9 usually leads to apoptosis, PIDDosome-based activation of caspase-2 is not toxic, and cells survive even if a notable fraction of the caspase-2 pool is activated. A second signal apparently is required for full commitment to caspase-2-mediated apoptosis. The caspase-2-activating PIDDosome complex, therefore, most resembles the inflammasome complex (20) , which leads to caspase-1 activation without causing cell death. There is increasing evidence that even "apoptotic" caspases have pleiotropic effects. Caspase-8 activity is required for T cell proliferation (21) , whereas caspase-3 regulates cell cycle progression in B cells (22) . Similarly, active caspase-2 in cells expressing increased amounts of PIDD may have apoptosisindependent roles in processes such as DNA repair. Under genotoxic conditions, a fraction of nuclear caspase-2 might translocate to the cytoplasm, cleave Bid, and thereby accelerate apoptosis (8, 9) . The identification of the PIDDosome as a platform for caspase-2 activation should facilitate the unraveling of these still poorly defined signaling pathways.
